Skip to main content
. 2018 Nov 20;51(3):1144–1155. doi: 10.4143/crt.2018.508

Fig. 5.

Fig. 5.

The developed nomogram predicting 3-year progression-free survival. Hb, hemoglobin; NAC, neoadjuvant chemotherapy; PDS, primary debulking surgery; IDS, interval debulking surgery; CA-125, cancer antigen 125.